NEW YORK (GenomeWeb News) - Protagen said yesterday that it is partnering with the Center for Applied Proteomics in Germany and Shunde Kangdi Antibody Biotech and the Beijing Proteome Research Center in China to develop antibodies against liver proteins.
 
Protagen said it will create custom protein biochips for quantitative analysis of binding profiles of antibody candidates. The biochips also will analyze off-target activities of the antibody candidates.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.